Literature DB >> 9212233

Soluble and membrane isoforms of Fas/CD95 in fresh adult T-cell leukemia (ATL) cells and ATL-cell lines.

K Sugahara1, Y Yamada, Y Hiragata, Y Matsuo, K Tsuruda, M Tomonaga, T Maeda, S Atogami, K Tsukasaki, S Kamihira.   

Abstract

Fas, also designated as Apo-1 and CD95, is a cell membrane receptor (mFas) involved in apoptotic cell death. A soluble form (sFas) lacking the transmembrane domain due to alternative splicing has been isolated. Abnormal expression of sFas and mFas is likely to be involved in lymphoproliferative disorders and auto-immune diseases. Adult T-cell leukemia (ATL) caused by human T-cell-leukemia virus type-1 (HTLV-1) is well known to be a T-cell neoplasm with strong mFas expression, suggesting a role of Fas in the pathology of the disease. We examined protein and mRNA expression of the 2 isoforms of Fas in fresh ATL cells and ATL cell lines. In general, mFas was strongly expressed in ATL cells, and sFas levels in sera were high, especially in malignant ATL. However, expression of the isoforms in some cases of ATL varied; there was no mFas expression on the cell surface and sFas levels were high in serum. In contrast, all ATL cell lines examined showed strong mFas expression and scarce production of sFas in the supernatant, corresponding to strong expression of full-length Fas mRNA and weak to negative expression of alternatively spliced mRNA lacking the transmembrane domain. Our findings indicate that the mode of expression of Fas isoforms in ATL cells is not always homogenous and that Fas may play a role in the malignant behavior and oncogenesis of ATL.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9212233     DOI: 10.1002/(sici)1097-0215(19970703)72:1<128::aid-ijc18>3.0.co;2-f

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Molecular cloning and characterisation of the rock bream, Oplegnathus fasciatus, Fas (CD95/APO-1), and its expression analysis in response to bacterial or viral infection.

Authors:  Ji-Min Jeong; Ju-Won Kim; Hyoung-Jun Park; Jeong-Hun Song; Do-Hyung Kim; Chan-Il Park
Journal:  Results Immunol       Date:  2011-07-14

2.  HTLV-2 Tax immortalizes human CD4+ memory T lymphocytes by oncogenic activation and dysregulation of autophagy.

Authors:  Tong Ren; Wen Dong; Yoshinori Takahashi; Di Xiang; Yunsheng Yuan; Xin Liu; Thomas P Loughran; Shao-Cong Sun; Hong-Gang Wang; Hua Cheng
Journal:  J Biol Chem       Date:  2012-08-13       Impact factor: 5.157

3.  Clinical relevance of survivin as a biomarker in neoplasms, especially in adult T-cell leukemias and acute leukemias.

Authors:  Kazuyuki Sugahara; Akiko Uemura; Hitomi Harasawa; Hiroshi Nagai; Yoichi Hirakata; Masao Tomonaga; Kenn Murata; Hiroshi Sohda; Toru Nakagoe; Sin-ichi Shibasaki; Yasuaki Yamada; Shimeru Kamihira
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490

4.  Possible attenuation of fas-mediated signaling by dominant expression of caspase-8 aberrant isoform in adult T-cell leukemia cells.

Authors:  Kazuyuki Sugahara; Tomomi Hayashi; Natsuko Dateki; Yoichi Hirakata; Hitomi Harasawa; Masao Tomonaga; Yasuaki Yamada; Shimeru Kamihira
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

5.  Clinical and oncological significance of aberrant Fas (APO-1/CD95) isoform expression in adult T-cell leukemia.

Authors:  S Kamihira; Y Yamada; T Maeda
Journal:  Indian J Clin Biochem       Date:  2000-08

6.  Fas gene mutation in the progression of adult T cell leukemia.

Authors:  T Maeda; Y Yamada; R Moriuchi; K Sugahara; K Tsuruda; T Joh; S Atogami; K Tsukasaki; M Tomonaga; S Kamihira
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.